• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Structural Heart

Medtronic enrolls first patient in trial of Evolut TAVR system in patients with aortic stenosis

May 2, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced today that it enrolled the first patient in its Expand TAVR II pivotal trial. Expand TAVR II will evaluate the self-expanding, supra-annular Evolut transcatheter aortic valve replacement (TAVR) platform in patients with moderate, symptomatic aortic stenosis (AS), a population outside of current guidelines and indications for TAVR. According to a news release, […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Replacement Heart Valves, Structural Heart Tagged With: Medtronic, tavr

Late-breaking data supports use of Boston Scientific’s S-ICD, Watchman FLX devices

May 2, 2022 By Sean Whooley

Late-breaking data highlighted the effectiveness of Boston Scientific’s (NYSE:BSX) S-ICD technology and Watchman FLX device. Multiple trials, for which data was presented at the Heart Rhythm Society (HRS) Heart Rhythm 2022 conference, backed Marlborough, Massachusetts-based Boston Scientific’s subcutaneous implantable cardiac defibrillators (S-ICD) against transvenous ICDs (TV-ICD) — and the Watchman FLX left atrial appendage closure […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, News Well, Structural Heart Tagged With: Boston Scientific, HRS 2022, Stroke

Medtronic investigates HVAD pump welds after patient deaths

April 29, 2022 By Jim Hammerand

Medtronic (NYSE:MDT) is investigating a new problem with its HeartWare Ventricular Assist Device (HVAD) nearly one year after halting sales and new implantations of the device. Fridley, Minnesota-based Medtronic said it received three complaints of suspected pump thrombosis in patients. Two of the patients died after their heart pumps were exchanged. Medtronic found a malfunction when inspecting […]

Filed Under: Blog, Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Implants, News Well, Recalls, Regulatory/Compliance Tagged With: FDA, Medtronic

Abbott announces U.S. launch of Amplatzer steerable delivery sheath for Amulet device

April 28, 2022 By Sean Whooley

Abbott (NYSE:ABT) announced today that it made the Amplatzer steerable delivery sheath commercially available in the U.S. The Amplatzer steerable delivery sheath works with the Amplatzer Amulet left atrial appendage (LAA) occluder to treat people with AFib who are at risk of ischemic stroke According to a news release, the Amulet with dual-seal technology offers […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, Featured, News Well, Structural Heart Tagged With: Abbott, Stroke

Edwards Lifesciences shares fall on Street-beating Q1 results

April 26, 2022 By Jim Hammerand

Edwards Lifesciences (NYSE: EW) posted first-quarter results today that beat the consensus forecast on Wall Street. It also reaffirmed its outlook for the rest of the year, with CEO Michael Mussallem saying, “We are hopeful the worst of the pandemic is behind us.” The Irvine, California–based cardio device company reported profits of $373.6 million, or […]

Filed Under: Blog, Business/Financial News, Cardiovascular, Featured, MassDevice Earnings Roundup, News Well, Replacement Heart Valves, Structural Heart, Wall Street Beat Tagged With: BTIG, Edwards Lifesciences, Michael Mussallem

18 of the world’s most innovative medical technologies

April 26, 2022 By Danielle Kirsh

Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that have received a Prix Galien award […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Diabetes, Diagnostics, Digital Health, Endoscopic, Featured, Imaging, Implants, Neuromodulation/Neurostimulation, Oncology, Orthopedics, Patient Monitoring, Replacement Heart Valves, Stents, Structural Heart Tagged With: Abbott, Alcon, Biosense Webster, Boston Scientific, Devices4Care, Diatropix, Genmab, Germitec, Hexacath, Johnson & Johnson, Medtronic, Moveo, nanobiotix, Prix Galien International, Siemens Healthineers, sysmex, The Galien Foundation, The Hubrecht Institute, Urgo Medical, VRelax

Recall of Medtronic’s Harmony delivery catheter is Class I

April 26, 2022 By Sean Whooley

The FDA today announced a Class I recall — the most serious kind — for the Medtronic (NYSE:MDT) Harmony delivery catheter system. Medtronic designed the Harmony transcatheter pulmonary valve (TPV) system for treating a leaky native or surgically repaired right ventricular outflow tract (RVOT). It consists of a transcatheter pulmonary valve and a delivery catheter (the […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Replacement Heart Valves, Structural Heart Tagged With: FDA, Medtronic

FDA approves Biotronik’s programmer for implanted cardiac rhythm management devices

April 26, 2022 By Sean Whooley

Biotronik announced today that the FDA approved its Renamic Neo programmer for implanted cardiac rhythm management devices. Lake Oswego, Oregon-based Biotronik designed its Renamic Neo programmer for implanted devices, including ICDs, pacemakers and implantable cardiac monitors. According to a news release, Renamic Neo offers LifeSupport for clinicians to share the programmer screen with or grant […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Health Technology, Implants, News Well, Patient Monitoring, Regulatory/Compliance Tagged With: Biotronik, FDA

Abiomed announces first Impella BTR heart pump implant

April 26, 2022 By Danielle Kirsh

Abiomed (Nasdaq:ABMD) today announced the first patient in the world was successfully treated with its Impella Bridge-to-Recovery (BTR) as part of an early feasibility study. The first implant was performed by Dr. Duc Thinh Pham and Dr. Jane Wilcox at Northwestern Medicine Bluhm Cardiovascular Institute in Chicago. Impella BTR is a forward flow heart pump implanted […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Implants, News Well, Structural Heart Tagged With: Abiomed

Ariste Medical co-founder sees great potential for drug-coated implants and orthopedics

April 18, 2022 By Jim Hammerand

It’s been more than a decade since Lisa Jennings launched not one but two companies in the Great Recession. In 2020, she sold CirQuest Labs to MLM Medical Labs, where Jennings serves as chief scientific officer and managing director of U.S. operations. More recently, her pre-commercial medtech development startup, Ariste Medical, won FDA 510(k) approval for […]

Filed Under: Blog, Cardiovascular, Catheters, Drug-Device Combinations, Drug-Eluting Stents, Endoscopic, Featured, Implants, News Well, Orthopedics, Pharmaceutical, Stent Grafts, Stents Tagged With: Ariste Medical, Ortho

Where are LVADs headed in the future?

April 18, 2022 By Chris Newmarker

Abbott (NYSE:ABT) became the dominant provider of left ventricular assist devices (LVADs) after Medtronic’s decision last year to leave the market. The Abbott HeartMate 3‘s advantages include its Full MagLev flow technology — which involves a free-floating magnetically levitated rotor that prevents surface-to-surface contact that could cause blood trauma. In addition, system batteries provide up […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Structural Heart Tagged With: Abbott, DeviceTalks Boston

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 202
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS